Table 2 Serum vitamin D concentration at baseline and 3 months following administration of the participants.
Groups | Serum vitamin D concentration (ng/ml) | P-value† | |
|---|---|---|---|
At baseline | After 3–6 months | ||
Vitamin D group | 12.5 ± 5.3 | 37.9 ± 6.3 | < 0.001 |
Placebo group | 12.6 ± 4.6 | 12.7 ± 5.6 | 0.95 |
P-value‡ | 0.95 | < 0.001 | |